252 Participants Needed

Dexamethasone + Dexmedetomidine for Post-Op ACL Repair Pain

(AADDCToR Trial)

DB
Overseen ByDidem Bozak
Age: 18 - 65
Sex: Any
Trial Phase: Phase 4
Sponsor: Women's College Hospital
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how two drugs, dexamethasone (a corticosteroid) and dexmedetomidine (a sedative), reduce pain after ACL (knee ligament) surgery. Researchers aim to determine if using these drugs alone or together eases recovery by reducing pain. Participants will receive either one of the drugs, both drugs combined, or a placebo (inactive treatment). Individuals who have undergone ACL repair and do not have diabetes, chronic pain, or a history of drug dependence may be suitable for this study. As a Phase 4 trial, the study focuses on understanding how these FDA-approved and effective treatments can benefit more patients.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you have a history of long-term opioid use or certain medical conditions, you may not be eligible to participate.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for guidance.

What is the safety track record for these treatments?

Research has shown that dexamethasone and dexmedetomidine are generally safe and effective for managing post-surgical pain. Studies have found that dexamethasone reduces pain and decreases the need for painkillers after surgery. It also helps with swelling and lessens nausea and fatigue.

For dexmedetomidine, research indicates it lowers pain levels and improves recovery after surgery. It stabilizes vital signs and enhances overall treatment effectiveness. When used together, dexamethasone and dexmedetomidine provide better pain relief than using either one alone.

Both treatments have a strong safety record in humans, supported by multiple studies. Participants in past trials generally tolerated these treatments well, with few serious side effects reported.12345

Why are researchers enthusiastic about this study treatment?

Researchers are excited about combining dexamethasone and dexmedetomidine for post-op ACL repair pain because this pairing offers a potentially enhanced approach to pain management. Unlike traditional pain treatments like opioids, which can have significant side effects and addiction risks, this combination targets pain through anti-inflammatory effects (dexamethasone) and sedation with analgesia (dexmedetomidine). Dexamethasone reduces swelling and inflammation, while dexmedetomidine provides calming and pain-relief effects, potentially reducing the need for opioids. Additionally, the use of these agents together could offer a more balanced and effective pain control strategy, minimizing side effects and improving recovery experiences for patients.

What evidence suggests that this trial's treatments could be effective for post-op ACL repair pain?

Research has shown that dexamethasone can reduce swelling and ease pain, nausea, and tiredness after surgery. It also provides longer-lasting pain relief. In this trial, some participants will receive dexamethasone alone, while others will receive dexmedetomidine alone. Studies indicate that dexmedetomidine effectively reduces pain and decreases the need for other pain medications after surgery. Additionally, one arm of this trial will test the combination of both dexamethasone and dexmedetomidine, which might improve pain control further, potentially reducing moderate-to-severe pain by an additional 20%. These treatments aim to make recovery from ACL repair surgery less painful and more comfortable.16789

Who Is on the Research Team?

Richard Brull, MD, FRCPC - Academics at ...

Richard Brull, MD

Principal Investigator

Women's College Hospital

Are You a Good Fit for This Trial?

This trial is for English-speaking individuals with a BMI under 40, who are in generally good health (ASA 1-3), and are about to undergo surgery for an Anterior Cruciate Ligament (ACL) injury.

Inclusion Criteria

English Speaking
BMI <40
I am in good to moderate health with manageable medical problems.

Exclusion Criteria

I have diabetes.
I don't have conditions that prevent me from getting regional anesthesia.
I have been taking opioids for a long time or have chronic pain.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo ACL repair surgery with adductor canal block and receive either dexamethasone, dexmedetomidine, their combination, or placebo to evaluate postoperative analgesia

1 day
1 visit (in-person)

Immediate Postoperative Monitoring

Participants are monitored for pain relief and opioid consumption in the PACU and up to 24 hours post-surgery

24 hours
Continuous monitoring

Follow-up

Participants are monitored for safety, effectiveness, and complications related to the nerve block and opioid use

2 weeks
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Dexamethasone
  • Dexmedetomidine
  • Saline
Trial Overview The study is testing the effectiveness of two drugs, Dexamethasone and Dexmedetomidine, used alone or combined as add-ons to the Adductor Canal Block (ACB), a pain management technique after ACL repair surgery.
How Is the Trial Designed?
4Treatment groups
Active Control
Placebo Group
Group I: Dexamethasone and DexmedetomidineActive Control3 Interventions
Group II: Dexamethasone vs. Control comparisonActive Control2 Interventions
Group III: Dexmedetomidine vs. Control comparisonActive Control2 Interventions
Group IV: Control Group-PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Women's College Hospital

Lead Sponsor

Trials
108
Recruited
43,700+

University Health Network, Toronto

Collaborator

Trials
1,555
Recruited
526,000+

Published Research Related to This Trial

In a study of 198 patients undergoing shoulder surgery, intravenous dexamethasone significantly prolonged the duration of analgesic blocks compared to dexmedetomidine, with block durations of 24.5 hours for dexamethasone versus 16.0 hours for dexmedetomidine.
Combining dexamethasone and dexmedetomidine did not provide any additional benefit over using dexamethasone alone, indicating that dexamethasone is the more effective adjunct for enhancing pain relief after interscalene blocks.
Analgesic duration of interscalene block after outpatient arthroscopic shoulder surgery with intravenous dexamethasone, intravenous dexmedetomidine, or their combination: a randomized-controlled trial.Rodrigues, D., Amadeo, RJJ., Wolfe, S., et al.[2023]
In a study of 108 patients undergoing total knee arthroplasty, administering two doses of low-dose dexamethasone significantly reduced inflammatory markers (CRP and IL-6) and provided better pain relief compared to a placebo, particularly at 24 hours post-surgery.
Dexamethasone also decreased the incidence of postoperative nausea and vomiting (PONV) and postoperative fatigue, while showing no increase in the risk of surgical complications, indicating it is both effective and safe for enhancing recovery after knee surgery.
Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study.Xu, B., Ma, J., Huang, Q., et al.[2018]
A meta-analysis of five randomized controlled trials found that perineural dexamethasone provides similar pain relief and block duration compared to intravenous dexamethasone after shoulder arthroscopy, indicating both methods are effective.
There were no significant differences in pain scores, opioid consumption, or incidence of nausea/vomiting between the two administration routes, suggesting that either method can be safely used for pain management.
Analgesic comparison between perineural and intravenous dexamethasone for shoulder arthroscopy: a meta-analysis of randomized controlled trials.Huang, L., Li, P., Zhang, L., et al.[2022]

Citations

Low-dose Perioperative Dexamethasone Improves 24-hour ...The administration of dexamethasone in the perioperative period can decrease inflammatory response and hence reduce post-operative pain, nausea, and fatigue.
Study on the Effect of Dexamethasone and Sodium ...The trial aims to provide valuable information on whether dexamethasone can effectively reduce pain and improve recovery after ACL surgery.
Effects of the addition of dexamethasone on postoperative ...The present results confirm that the addition of dexamethasone also prolongs the duration of analgesia and motor block of proximal lower ...
The efficacy of dexamethasone on pain management ...Overall, compared with control group for knee arthroscopy, dexamethasone supplementation has no notable effect on pain scores at 4 to 6 hours (Std. MD = 0.99; ...
Aspiration and Corticosteroid Injection Are Safe After ACL InjuryAspiration and corticosteroid injection in the knee is safe and beneficial for young, healthy patients following anterior cruciate ligament (ACL) rupture and ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/29555525/
The efficacy and safety of dexamethasone for pain ...Conclusion: Dexamethasone decreases pain scores within 48 h postoperatively and is associated with significantly reduced narcotic consumption.
Perioperative dexamethasone: Effects on length of stay, ...This investigation aims to evaluate the effects of perioperative dexamethasone on LOS, post-operative outcomes, and adverse event rates for trauma patients.
A meta-analysis of dexamethasone for pain management in...Previous studies have demonstrated that dexamethasone appeared to be effective and safe for postoperative pain control in arthroplasties. Additionally, ...
Efficacy of Weight-Based Low-Dose Intravenous ...Results. The dexamethasone group demonstrated significantly lower pain scores at all measured intervals up to 60 hours postoperatively (p < 0. ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security